 | Up a level |
Tarasco, Erika; von Krogh, Anne Sophie; Hrdlickova, Radomira; Braschler, Thomas R; Iwaniec, Teresa; Knöbl, Paul N; Hamada, Eriko; Pikovsky, Oleg; Farese, Stefan; Gutwein, Odit; Kessler, Petr; Schultz, Nina H; von Auer, Charis; Windyga, Jerzy; Friedman, Kenneth; Hrachovinova, Ingrid; George, James N; Matsumoto, Masanori; Schneppenheim, Reinhard; Lämmle, Bernhard; ... (2022). Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease. Research and practice in thrombosis and haemostasis, 6(7), e12814. Wiley 10.1002/rth2.12814
Braschler, Thomas R; Zeerleder, Sacha (2022). [Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency]. Therapeutische Umschau, 79(6), pp. 295-300. Hogrefe 10.1024/0040-5930/a001364
Kremer Hovinga, Johanna A.; Braschler, Thomas R; Buchkremer, Florian; Farese, Stefan; Hengartner, Heinz; Lovey, Pierre-Yves; Largiadèr, Carlo R.; Mansouri Taleghani, Behrouz; Tarasco, Erika (2020). Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland. Hämostaseologie, 40(S 01), S5-S14. Thieme 10.1055/a-1282-2264
Baerlocher, Gabriela M.; Haubitz, Monika; Braschler, Thomas R; Brunold, Claudio; Burington, Bart; Oppliger Leibundgut, Elisabeth; Go, Ning (2019). Imetelstat inhibits growth of megakaryocyte colony-forming units from patients with essential thrombocythemia. Blood advances, 3(22), pp. 3724-3728. American Society of Hematology 10.1182/bloodadvances.2019000167
